PATIENT CONSENSUS ON PICO SCOPING FOR THE HEALTH TECHNOLOGY ASSESSMENT (HTA) REGULATION: A CASE FOR DELPHI METHODOLOGY

被引：0

作者：

Arca, E. ^{[1
]}

Barlassina, A. ^{[2
]}

Eze, A. ^{[3
]}

Strammiello, V ^{[4
]}

机构：

[1] OPEN Hlth, Brussels, Belgium

[2] OPEN Hlth HEOR Market Access, Brussels, Belgium

[3] OPEN Hlth HEOR Market Access, Rotterdam, Netherlands

[4] European Patients Forum, Brussels, Belgium

来源：

VALUE IN HEALTH | 2024年 / 27卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

HTA98

引用

页码：S372 / S372

页数：1

共 50 条

[21] A HTA of what? Reframing through including patient perspectives in health technology assessment processes
Gunn, Callum J. J.
Regeer, Barbara J. J.
Zuiderent-Jerak, Teun
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
[22] COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT (HTA) RANKINGS BY GERMAN AND FRENCH HTA AGENCIES
Hu, I
Zheng, J.
Hu, X. H.
VALUE IN HEALTH, 2015, 18 (03) : A96 - A97
[23] How Delphi studies in the health sciences find consensus: a scoping review
Schifano, Julia
Niederberger, Marlen
SYSTEMATIC REVIEWS, 2025, 14 (01)
[24] Patient Perspectives: An Integral Part of Health Technology Assessment Methodology
Spangler, Jason
Huth, Tiffany
Xie, Richard
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2022, 38 (01)
[25] Health Technology Assessment (HTA) und gesundheitsrechtliche Regulierung
Dieter Hart
MedR - Medizinrecht, 2001, 19 (1) : 1 - 8
[26] Observational studies and health-technology assessment (HTA)
Berntorp, E.
HAEMOPHILIA, 2012, 18 : 14 - 14
[27] Thematic analysis in integrated health technology assessment (HTA)
English, Bethany
Mumford, Andrew
Munetsi, Lorraine
QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S178 - S178
[28] A SCOPING REVIEW OF HEALTH TECHNOLOGY ASSESSMENT AGENCY (HTA) AND HEALTH ECONOMIC (HE) MODELLING GUIDELINES FOR IDENTIFICATION OF HEALTH ECONOMIC MODEL INPUTS
Lister, J.
Paisley, S.
Tappenden, P.
Carroll, C.
VALUE IN HEALTH, 2023, 26 (12) : S375 - S375
[29] Health Technology Assessment (HTA) evidence, regulatory classification and reimbursement of medicine: the case of glucosamine
Luksameesate, Parnnaphat
Taychakhoonavudh, Suthira
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (04) : 600 - 606
[30] Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives
van Overbeeke, Eline
Forrester, Valerie
Simoens, Steven
Huys, Isabelle
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (01): : 119 - 128

← 1 2 3 4 5 →